Why Krill Oil Is Different: New 2026 Research on Omega-3 Delivery, Arterial Health, and Astaxanthin

Fish oil has dominated the omega-3 supplement market for decades, but new research is raising an important question: does the form in which EPA and DHA are delivered matter as much as the amount on the label?

Two randomized human trials published in 2026 provide new evidence that krill oil behaves differently from conventional fish oil. One found that krill oil produced substantially greater increases in circulating EPA and DHA than an equal amount of omega-3 from fish oil [1]. Another found improvements in arterial stiffness and platelet-related measures after 12 weeks of Antarctic krill oil supplementation [2].

At the same time, new research on astaxanthin, the red antioxidant naturally associated with marine organisms such as krill, is adding another dimension to the story [3] [4].

That combination makes Healthmasters’ HEMMLA Body Balance Krill Oil particularly timely. HEMMLA combines Antarctic krill oil and phospholipid-bound EPA and DHA with a substantial 12 mg of astaxanthin per two capsules, providing more than simply another source of fish-derived omega-3s.

Krill Oil and Fish Oil Are Not Chemically Identical

EPA and DHA are the two marine omega-3 fatty acids most commonly associated with cardiovascular, neurological, and cellular health. Conventional fish oil generally delivers these fatty acids primarily in triglyceride or ethyl-ester forms. Krill oil is different because a substantial portion of its EPA and DHA is carried in phospholipids [1].

Phospholipids are major structural components of cell membranes. Each molecule contains a water-compatible portion and a fat-compatible portion, allowing it to interact with both watery and fatty environments.

Researchers have long questioned whether this structure changes how the body handles omega-3 fatty acids.

A new randomized controlled trial published in The American Journal of Clinical Nutrition in 2026 directly tested that question [1].

Researchers enrolled 72 healthy adults and randomly assigned them to either krill oil or fish oil for 12 weeks. Importantly, the two groups received the same amount of omega-3 fatty acids: 1.1 grams per day [1].

That makes the study particularly useful. Rather than simply comparing a large dose of one product with a small dose of another, the researchers attempted to isolate the effect of the omega-3 delivery form.

About 1.5 Times Greater EPA and DHA Increases

Blood samples were collected before supplementation and again after 1, 2, 4, and 12 weeks [1].

By the end of the study, EPA had increased significantly more in the krill-oil group. The increase in EPA was approximately 1.4 times greater with krill oil than with fish oil [1].

The difference for DHA was even larger. The rise in plasma DHA was approximately 1.5 times greater with krill oil [1].

Overall, the investigators described increases in EPA and DHA with krill oil as roughly 1.5-fold greater than those produced by the equivalent omega-3 dose from fish oil [1].

EPA also increased rapidly. Much of the increase in the krill group occurred during the first week, while DHA climbed for several weeks before reaching a plateau [1].

It would be tempting to simply call this “better absorption,” but the researchers were more careful. They explained that the higher blood concentrations may not result solely from more omega-3 passing through the intestine. Instead, phospholipid-bound EPA and DHA may be processed, transported, retained, and incorporated differently after digestion than triglyceride-bound omega-3s [1].

That distinction is important. The finding is not merely that krill oil contains EPA and DHA. It suggests that the molecular package carrying those fatty acids can affect what happens to them after they are consumed.

Why Phospholipids Matter

Most people recognize EPA and DHA, but phospholipids receive much less attention.

Cell membranes are built largely from a phospholipid bilayer. These membranes determine what enters and leaves cells and provide the physical environment in which many receptors, enzymes, and signaling systems operate.

Krill oil naturally packages much of its omega-3 content inside phospholipids, particularly phosphatidylcholine [1].

The 2026 researchers proposed that this structure may influence the way EPA and DHA circulate and are retained in tissues. Previous research has also suggested that phospholipid-bound omega-3s can produce larger increases in omega-3 status than might be expected simply from their labeled EPA and DHA dose [1].

This is one of the primary reasons HEMMLA is different from an ordinary fish-oil capsule. Its Antarctic krill oil supplies omega-3 fatty acids within this phospholipid-rich marine matrix rather than treating EPA and DHA as isolated ingredients.

New Evidence for Arterial Function

A second 2026 randomized, double-blind, placebo-controlled study examined Antarctic krill oil from an entirely different perspective [2].

Researchers recruited 120 healthy adults between 19 and 70 years old and assigned them to receive 375 mg of krill oil, 750 mg of krill oil, or placebo each day for 12 weeks [2].

They measured platelet activity along with several cardiovascular markers, including brachial-ankle pulse wave velocity [2].

Pulse-wave velocity measures how quickly a pressure wave travels through the arteries. In general, a faster wave indicates that arteries are stiffer, while a slower wave indicates greater arterial elasticity.

After 12 weeks, the 750 mg krill-oil group showed a significant reduction in arterial stiffness compared with placebo [2].

The study also found significant differences in platelet aggregation measurements, suggesting an effect on platelet behavior and circulation [2].

This does not mean krill oil has been proven to prevent heart attacks or cardiovascular disease. The participants were healthy, the trial lasted only 12 weeks, and the study measured intermediate markers rather than actual cardiovascular events [2].

Still, arterial stiffness is a much more tangible physiological outcome than simply showing that an antioxidant changed a laboratory marker. The result provides another reason researchers are becoming interested in krill oil as more than an alternative source of EPA and DHA.

HEMMLA Adds 12 mg of Astaxanthin

HEMMLA also brings another marine nutrient into the formula: astaxanthin.

Astaxanthin is the reddish carotenoid responsible for much of the color seen in krill, salmon, shrimp, and other marine animals. Unlike EPA and DHA, astaxanthin is not an omega-3 fatty acid. It is a fat-soluble antioxidant.

HEMMLA formula provides 12 mg of astaxanthin per two capsules, a dose that becomes particularly interesting in light of a newly published 2026 meta-analysis [3].

Researchers combined 16 clinical trials involving 694 overweight or obese adults [3]. Astaxanthin supplementation significantly reduced several measures of oxidative stress and inflammation, including malondialdehyde, C-reactive protein, and interleukin-6 [3].

The researchers also found small but statistically significant improvements in triglycerides, total cholesterol, LDL cholesterol, and HDL cholesterol [3].

Especially relevant to HEMMLA, subgroup analysis suggested that doses of at least 12 mg per day and interventions lasting 12 weeks or longer produced more pronounced lipid effects [3].

That does not establish that HEMMLA will reproduce those outcomes, because the studies involved different astaxanthin preparations and populations. However, its 12 mg serving places the formula directly within a dose range now receiving substantial clinical attention.

Astaxanthin and Oxidative Stress

Another 2026 meta-analysis examined astaxanthin specifically in the setting of exercise-induced oxidative stress [4].

Seven randomized controlled trials with 188 participants were included. Doses ranged from 4 to 28 mg per day [4].

Astaxanthin significantly reduced advanced oxidation protein products, or AOPPs, a marker of oxidative damage to proteins [4].

Not every marker improved. Measures such as malondialdehyde, creatine kinase, IL-6, and several antioxidant enzymes did not show consistent significant changes in this particular analysis [4].

However, human research increasingly supports biological antioxidant activity, while the magnitude and exact effects vary with population, dose, and study design [3,4].

Conclusion

The new research helps explain why comparing omega-3 supplements solely by the milligrams of EPA and DHA printed on the label may miss part of the picture. In the 2026 head-to-head trial, researchers gave participants the same omega-3 dose, yet krill oil produced considerably larger increases in circulating EPA and DHA [1].

Another randomized trial found that Antarctic krill oil affected arterial stiffness and platelet measurements after only 12 weeks [2]. And two new meta-analyses strengthen the human evidence behind astaxanthin, particularly for oxidative stress and certain cardiometabolic markers [3] [4].

Together, these findings fit remarkably well with the design of Healthmasters’ HEMMLA Body Balance Krill Oil.

HEMMLA provides Antarctic krill oil with naturally phospholipid-associated EPA and DHA while adding 12 mg of astaxanthin per two capsules. Rather than simply attempting to deliver more oil, the formula emphasizes the form of the omega-3s and the marine antioxidant environment surrounding them.

For people looking for omega-3 support for cardiovascular health, brain function, cellular membranes, and healthy aging, HEMMLA offers a more comprehensive approach than conventional fish oil alone: phospholipid-bound EPA and DHA combined with a clinically relevant dose of astaxanthin in one marine-based formula.

References

[1] Loukil, I., Vachon, A., Çaku, A., & Plourde, M. (2026). Krill oil increases plasma omega-3 fatty acids more than fish oil in healthy adults: A double-blind randomized controlled trial. The American Journal of Clinical Nutrition, 124(1), 101346. https://www.sciencedirect.com/science/article/pii/S0002916526001553

[2] Chai, H., Yoo, M., Hong, I. K., Kim, E. R., Lee, H. G., & Paek, Y. J. (2026). Efficacy and safety of Antarctic krill oil extract (FJH-KO) on platelet aggregation and arterial stiffness in healthy adults: A randomized, double-blind, placebo-controlled trial. Journal of Dietary Supplements, 23(4), 535-552. https://pubmed.ncbi.nlm.nih.gov/42415693/

[3] Pei, A., Xu, J., Ni, X., et al. (2026). Astaxanthin supplementation and cardiometabolic risk factors in overweight and obese adults: A GRADE-assessed systematic review and meta-analysis. Nutrition & Metabolism. https://link.springer.com/article/10.1186/s12986-026-01188-z

[4] You, T., Peng, K., Zhao, K., Liu, S., Sun, F., Yu, B., Dou, Y., Tang, J., Jiang, W., & Liu, C. (2026). Effects of astaxanthin supplementation on exercise-induced oxidative stress: A systematic review and meta-analysis of randomized controlled trials. 3 Biotech, 16(3), 98. https://pubmed.ncbi.nlm.nih.gov/41710469/

*The matters discussed in this article are for informational purposes only and not medical advice. Please consult your healthcare practitioner on the matters discussed herein.

*These statements have not been evaluated by the Food and Drug Administration. Healthmasters' products are not intended to diagnose, treat, cure, or prevent any disease.